Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - 21 CFR Part 520
          - [Docket No. FDA-2014-N-0002]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notification of withdrawal of approval.

# SUMMARY:

The Food and Drug Administration (FDA) is withdrawing approval of an abbreviated new animal drug application (ANADA) for an oxytetracycline soluble powder used to make medicated drinking water for livestock and poultry. This action is being taken at the sponsor's request because this product is no longer manufactured or marketed.

# DATES:

Withdrawal of approval is effective December 26, 2014.

# FOR FURTHER INFORMATION CONTACT:

                        Sujaya Dessai, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9075,                         *sujaya.dessai@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

Vétoquinol N.-A., Inc., 2000 chemin Georges, Lavaltrie (PQ), Canada, J5T 3S5 has requested that FDA withdraw approval of ANADA 200-305 for Oxytetracycline Hydrochloride Soluble Powder because the product is no longer manufactured or marketed. Note this ANADA was identified as being affected by guidance for industry (GFI) #213, “New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209”, December 2013.

                    Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116                     *Notice of withdrawal of approval of application*                     (21 CFR 514.116), notice is given that approval of ANADA 200-305, and all supplements and amendments thereto, is hereby withdrawn, effective December 26, 2014.                

                    Elsewhere in this issue of the                     **Federal Register**                    , FDA is amending the animal drug regulations to reflect the voluntary withdrawal of approval of this application.                

Dated: December 9, 2014.

Bernadette Dunham,

Director, Center for Veterinary Medicine.

[FR Doc. 2014-29248 Filed 12-12-14; 8:45 am]

BILLING CODE 4164-01-P